Trial · NCT01265550
Outcomes54
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 54
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Achieving at Least a 50% Improvement in the Gastroesophageal Reflux Disease Health-related Quality of Life Index (GERD-HRQL) From Baseline to 12 Months | 12 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Enrolled Participants With Esophageal Ulceration. | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for esophageal ulceration. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Reflux Esophagus. | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for reflux esophagus. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Eosinophilic Esophagitis | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for eosinophilic esophagitis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Active Ulceration of the Stomach and/or Duodenum. | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for active ulcerations of the stomach and/or duodenum | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Neoplasm of the Esophagus, Stomach or Duodenum | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for neoplasm of the esophagus, stomach or duodenum | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Candida Esophagitis. | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for candida esophagitis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Gastric Outlet Obstruction | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for gastric outlet obstruction | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Achalasia | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for achalasia | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Aperistalsis | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for aperistalsis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Distal Esophageal Spasm | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for distal esophageal spasm | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Nutcracker Esophagus | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for nutcracker esophagus | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Ineffective Esophageal Motility | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for ineffective esophageal motility | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Rapid Contraction | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for rapid contraction | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Hypertensive Peristalsis | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for hypertensive peristalsis | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Jackhammer Esophagus | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for jackhammer esophagus | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Weak Peristalsis I | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for weak peristalsis I | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Weak Peristalsis II | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for weak peristalsis II | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Anxiety and/or Depression | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for anxiety and/or depression | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Enrolled Participants With Functional Heartburn | Screening | The Overall number of participants analyzed represents those Enrolled Participants who were evaluated for functional heartburn | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01265550/outcomes